Medtronic reports first quarter fiscal 2026 financial results
1. Medtronic's Q1 FY26 revenue reached $8.6 billion, an 8.4% increase. 2. Adjusted revenue growth was 4.8% with cardiac solutions seeing substantial gains. 3. The company raised FY26 EPS guidance to $5.60-$5.66 due to strong Q1 performance. 4. Pulsed field ablation products contributed to nearly 50% revenue growth in Cardiac Ablation. 5. Medtronic received CE Mark for LigaSure RAS technology, enhancing surgical portfolio.